Vivos Therapeutics Inc
NASDAQ:VVOS
Vivos Therapeutics Inc
NASDAQ:VVOS
Price:
2.59 USD
5.28%
Market Closed
Updated:
Apr 29, 2024
Vivos Therapeutics Inc
Cash from Financing Activities
|
Vivos Therapeutics Inc
Cash from Financing Activities Peer Comparison
Comparables:
DVA
DGX
CVS
CI
LH
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Vivos Therapeutics Inc
NASDAQ:VVOS
|
Cash from Financing Activities
$10.9m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
DaVita Inc
NYSE:DVA
|
Cash from Financing Activities
-$1.2B
|
CAGR 3-Years
14%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-9%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cash from Financing Activities
$83m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
CVS Health Corp
NYSE:CVS
|
Cash from Financing Activities
$2.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-41%
|
CAGR 10-Years
N/A
|
|
|
Cigna Corp
NYSE:CI
|
Cash from Financing Activities
-$4.3B
|
CAGR 3-Years
20%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-17%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cash from Financing Activities
-$10.4m
|
CAGR 3-Years
77%
|
CAGR 5-Years
63%
|
CAGR 10-Years
26%
|
See Also
What is Vivos Therapeutics Inc's Cash from Financing Activities?
Cash from Financing Activities
10.9m
USD
10.9m
USD
Based on the financial report for Dec 31, 2023, Vivos Therapeutics Inc's Cash from Financing Activities amounts to 10.9m USD.
What is Vivos Therapeutics Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
16%
16%
The average annual Cash from Financing Activities growth rates for Vivos Therapeutics Inc have been -23% over the past three years , 16% over the past five years .
You don't have any saved screeners yet
